Illán-Gala et al. (32) reported that although neither absolute CSF CHI3L1 levels nor the sAPPβ:CHI3L1 ratio significantly differed between FTD and ALS patients, CHI3L1 and global cognitive performance only correlated in the FTD subgroup. The gene discussed is CHI3L1; the disease is frontotemporal dementia.